These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. To edit or not to edit: regulation of ADAR editing specificity and efficiency. Deffit SN; Hundley HA Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708 [TBL] [Abstract][Full Text] [Related]
54. ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers. Liu WH; Chen CH; Yeh KH; Li CL; Wu YJ; Chen DS; Chen PJ; Yeh SH PLoS One; 2013; 8(12):e81922. PubMed ID: 24386085 [TBL] [Abstract][Full Text] [Related]
55. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer. Cho CJ; Myung SJ; Chang S Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248 [TBL] [Abstract][Full Text] [Related]
56. A robust model for quantitative prediction of the silencing efficacy of wild-type and A-to-I edited miRNAs. Tian S; Terai G; Kobayashi Y; Kimura Y; Abe H; Asai K; Ui-Tei K RNA Biol; 2020 Feb; 17(2):264-280. PubMed ID: 31601146 [TBL] [Abstract][Full Text] [Related]
57. A mammalian reporter system for fast and quantitative detection of intracellular A-to-I RNA editing levels. Gommans WM; McCane J; Nacarelli GS; Maas S Anal Biochem; 2010 Apr; 399(2):230-6. PubMed ID: 20051222 [TBL] [Abstract][Full Text] [Related]
58. A-to-I editing in the miRNA seed region regulates target mRNA selection and silencing efficiency. Kume H; Hino K; Galipon J; Ui-Tei K Nucleic Acids Res; 2014 Sep; 42(15):10050-60. PubMed ID: 25056317 [TBL] [Abstract][Full Text] [Related]
59. ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature. Cesarini V; Silvestris DA; Galeano F; Tassinari V; Martini M; Locatelli F; Gallo A Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009036 [TBL] [Abstract][Full Text] [Related]